Novo Nordisk A/S
F:NOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Novo Nordisk A/S
F:NOV
|
DK |
|
Unicaja Banco SA
F:7UB
|
ES |
|
OUTFRONT Media Inc
F:76C0
|
US |
|
H
|
Hisense Home Appliances Group Co Ltd
XMUN:GKE
|
CN |
|
PriceSmart Inc
NASDAQ:PSMT
|
US |
|
OpGen Inc
F:650
|
US |
|
3
|
3M Co
SWB:MMM
|
US |
|
B
|
Biotest AG
F:BIO
|
DE |
|
K
|
Kroger Co
F:KOG
|
US |
|
A
|
Anfield Energy Inc
SWB:0ADN
|
CA |
|
N
|
Nippon Yusen KK
XMUN:NYKA
|
JP |
|
Corporacion Acciona Energias Renovables SA
MAD:ANE
|
ES |
|
B
|
Banca Mediolanum SpA
SWB:ME1
|
IT |
|
Iss A/S
OTC:ISFFF
|
DK |
|
C
|
Campbell Soup Co
XMUN:CSC
|
US |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
US |
|
T
|
Tenaris SA
F:TW1
|
LU |
|
Storagevault Canada Inc
F:0SV
|
CA |
|
Z
|
Z Holdings Corp
XBER:YOJ
|
JP |
|
B
|
Bluegreen Vacations Holding Corp
F:BCB1
|
US |
|
Honma Golf Ltd
F:HF5
|
JP |
|
F
|
Ford Motor Co
F:FMC1
|
US |
|
Bowen Coking Coal Ltd
ASX:BCBDB
|
AU |
Bankruptcy Probability
Novo Nordisk A/S's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Novo Nordisk A/S Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
894.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
275.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
Bayer AG
XETRA:BAYN
|
36.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
532.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
207B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.3B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Novo Nordisk A/S's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Novo Nordisk A/S has total debt of 118.9B DKK. This includes both short-term (0 DKK) and long-term (118.9B DKK) debt.
You can find a full breakdown on its Balance Sheet.
